Name: Structural Heart Imaging Market Size, Share, Industry, Forecast and outlook (2023-2030)
Brand: DataM Intelligence
SKU: MI4868
Price: 4350 USD
Availability: InStock

Structural Heart Imaging Market Size, Share, Growth Report 2023-2030

Structural Heart Imaging Market Size, Share, Industry, Forecast and outlook (2023-2030)

<h2>Structural Heart Imaging Market is segmented&nbsp;By Imaging Modality(Echocardiogram,Angiogram(CT and MRI)),&nbsp;By Procedure Type(Transcatheter Aortic Valve Replacement (TAVR), Surgical Aortic Valve Replacement (SAVR), Transcatheter Mitral, Valve Repair (TMVR), Left Atrial Appendage Closure (LAAC), Annuloplasty, Valvuloplasty, Others),&nbsp;By Application (Diagnosis and Surgery),&nbsp;By End user (Hospitals, Specialty Clinics, Cardiac Centers, Diagnostic Centers, Ambulatory Surgical Centers and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2023-2030</h2>

<h3>Market&nbsp;Overview</h3>

<blockquote>
The structural heart imaging market size was valued at USD 14085.8 mn in 2022, projected to reach USD 34912.46 mn by 2030, growing at a <a href="https://www.datamintelligence.com/research-report/structural-heart-imaging-market">CAGR of 12.4%</a> during the forecast period (2023-2030).
</blockquote>

Structural heart imaging (SHI) is a cardiology field that deals with valvular and non-valvular heart disease. SHI is a molecular imaging technology that is used to screen the heart. This method entails using high-resolution cameras to create different images of the heart&#39;s inner components, which aid in the proper diagnosis of the patient&#39;s condition. The two most popular imaging techniques that closely analyze the heart structure to reveal narrowing or blockage of blood arteries are echocardiograms and angiography (MRI, CT, etc.)

<h3>Market Scope</h3>

<table border="1" cellpadding="1" cellspacing="1">
	<tbody>
		<tr>
			<td>
			Metrics
			</td>
			<td>
			Details
			</td>
		</tr>
		<tr>
			<td>
			Market&nbsp;CAGR
			</td>
			<td>
			12.4%
			</td>
		</tr>
		<tr>
			<td>
			Segments Covered
			</td>
			<td>
			By Imaging Modality,&nbsp;By Procedure Type,&nbsp;By Application,&nbsp;By End user,&nbsp; and By Region
			</td>
		</tr>
		<tr>
			<td>
			Report Insights Covered
			</td>
			<td>
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
			</td>
		</tr>
		<tr>
			<td>
			Fastest Growing Region
			</td>
			<td>
			Asia Pacific
			</td>
		</tr>
		<tr>
			<td>
			Largest Market Share&nbsp;
			</td>
			<td>
			North America
			</td>
		</tr>
	</tbody>
</table>

<h3>Market Dynamics</h3>

Significant advances in structural heart interventions are expected to drive market growth.

Structural heart disease intervention is a game-changing breakthrough that has already displaced open surgery and enabled the treatment of a larger number of patients at a reduced cost. Significant progress has been made in structural cardiac interventions over the previous decade. The advancements in interventions and imaging are inextricably linked, from transcatheter aortic and pulmonic valve replacement to left atrial appendage occlusion procedures, percutaneous mitral repair techniques, and, more recently, transcatheter mitral valve replacement and tricuspid interventions. The commercial availability of 3-dimensional (3D) echocardiography, for instance, improved the efficiency, precision, and adaptability of the edge-to-edge repair technique. The collaboration of ultrasound and device firms continues to fuel breakthroughs in imaging that can then assist drive device innovation, thanks in part to imaging groups like the American Society of Echocardiography. Because of the imaging-intensive nature of all of these procedures, imagers must be familiar with a wide range of anatomical targets, modern imaging techniques, and the execution of numerous procedural interventions. Imagers have proven crucial to the field&#39;s continuous progress due to this information foundation. Thus, the market is expected to drive in the forecast period from the above statements.

Restraint:

Strict regulatory guidelines for equipment used in structural heart imaging, a lack of awareness regarding cardiac-specific structural imaging, and higher costs are some of the factors due to which the market is expected to hamper the market growth.

<h3>COVID-19 Impact Analysis</h3>

The COVID-19 pandemic has moderately impacted healthcare systems and the market. COVID-19 patients often have symptoms and signs of a respiratory tract infection, although cardiac manifestations, such as indicators of myocardial damage, are also prevalent. Myocardial injury in COVID-19 can be caused by an oxygen supply-demand imbalance resulting from hypoxia, hypoperfusion, tachycardia, microvascular and macrovascular thrombosis, or inflammation-related injury (especially in the setting of underlying structural heart disease or coronary atherosclerosis). Imaging aids in the early detection of disease in individuals with underlying cardiovascular disorders and the detection of cardiovascular consequences in people who have already been infected with SARS-CoV-2. Although symptoms of cardiac failure can be easily diagnosed using chest radiography, chest CT, and echocardiography, the best way to examine myocardial injury is with a cardiac MRI.

Moreover, the growing body of evidence indicating a high prevalence of cardiac involvement in COVID-19 patients warrants MRI in this patient population. In contrast, there is physical contact during imaging of the Covid-19 patients. Therefore, there are chances of spreading the virus, and the government has come out with guidelines during imaging(MRI, CT, and others). Additionally, the pandemic is interrupting the supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. Thus, the COVID-19 pandemic has affected the market. However, the situation is expected to improve gradually in the forecast period.

<h3>Segmentation Analysis</h3>

Angiogram segment is expected to hold the largest market share in the structural heart imaging market

The angiogram segment is expected to dominate in 2020. The segment&#39;s growth is benefited because demand for various imaging modalities is projected to rise as the need for diagnostic and effective imaging for detecting SHDs, particularly CHDs, grows. Moreover, Angiogram is further segmented into MRI and CT. In the anatomic and functional evaluation of cardiovascular disease, MRI is a critical diagnostic technique. 2D phase-contrast (2D-PC) MRI has been used in several procedures for blood flow quantification. Flow in four dimensions MRI is a volumetric acquisition that records the vector field of blood flow and anatomic pictures in a time-resolved manner. Compared to 2D-PC, it also makes acquisition easier and allows for a more precise and thorough hemodynamic assessment. With advancements in accelerated imaging, 4D flow MRI scanning times have been greatly reduced while image quality has been maintained, allowing this technology to move from research to everyday clinical practice. 4D flow MRI will likely become an essential component of cardiac imaging in practices dealing with congenital and acquired structural heart disease as experience grows, and 4D flow sequences and postprocessing software become more widely available.

Moreover, the use of advanced parallel imaging techniques like k-t GRAPPA has resulted in scan times that are more realistic, such as 8-12 minutes for 4D flow MRI of the aorta and 10-20 minutes for complete heart coverage. As a result, using 4D flow MRI in a clinical setting has become increasingly practicable, as seen by an increase in recent reports on the technique&#39;s utility in patient studies for measuring cardiac and vascular hemodynamics. Thus, the market is expected to hold the largest market share in the forecast period.

<h3>Geographical Analysis</h3>

North America region holds the largest market share in the global structural heart imaging market

In 2020, North America accounted for the highest revenue share. The increasing prevalence of Congenital heart defects, increasing demand for technologically improved technologies for the treatment of Structural Heart Disease, increased lifestyle change adoption, increased structural disease awareness, more preventative care, favorable government policies, clinical trials, and product launches by the key players in the region are some of the factors due to which the market is expected to boost in the forecast period.

For instance, according to the Centers for Disease Control and Prevention, The most frequent birth defects are congenital heart defects (CHDs), and babies are born with these problems. CHDs affect nearly 1% of―or about 40,000―births per year in the United States. Some CHDs, particularly mild forms, is growing in prevalence (the number of kids born with a heart defect divided by the total number of births), while the prevalence of other types has remained consistent. A ventricular septal defect is the most frequent type of heart abnormality (VSD). About 1 in 4 babies with CHD have a critical CHD. Infants with critical CHDs generally need surgery or other procedures in their first year of life.

Moreover, NuVera Medical, Inc. announced positive results from its non-randomized, single-center First-In-Human (FIH) study in October 2020, which looked at the NuVision ICE Catheter&#39;s feasibility in visualizing anatomical structures in patients undergoing structural heart procedures such as mitral or tricuspid valve repairs or LAAC. With improved 4D ICE imaging, the business hopes to improve the efficacy of transcatheter cardiac treatments. Thus, the North American region is expected to hold the largest market share in the forecast period from the above statements. &nbsp;&nbsp;

<h3>Competitive Landscape</h3>

Major key players in the structural heart imaging market are;

<ul>
	<li>Boston Scientific Corporation</li>
	<li>Circle Cardiovascular Imaging Inc</li>
	<li>Absolute Medical Services, Inc.</li>
	<li>Pie Medical Imaging B.V</li>
	<li>Siemens Healthineers GmbH</li>
	<li>Cardinal Health Inc</li>
	<li>Koninklijke Philips NV</li>
	<li>GE HealthCare</li>
	<li>Neusoft Medical Systems</li>
	<li>Shimadzu Corporation</li>
</ul>

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>Market Snippet by Imaging Modality</li>
		<li>Market Snippet by Procedure Type</li>
		<li>Market Snippet by Application</li>
		<li>Market Snippet by End User</li>
		<li>Market Snippet by Region</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>Market Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Significant advances in structural heart interventions are expected to drive market growth.</li>
			</ol>
			</li>
			<li>Restraints:
			<ol>
				<li>Strict regulatory guidelines for equipment used in structural heart imaging are expected to hamper the market growth.</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis

	<ol>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Unmet Needs</li>
	</ol>
	</li>
	<li>
	COVID-19 Analysis

	<ol>
		<li>Analysis of Covid-19 on the Market
		<ol>
			<li>Before COVID-19 Market Scenario</li>
			<li>Present COVID-19 Market Scenario</li>
			<li>After COVID-19 or Future Scenario</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid Covid-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion&nbsp;</li>
	</ol>
	</li>
	<li>
	By Imaging Modality

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality</li>
			<li>Market Attractiveness Index, By Imaging Modality Segment</li>
		</ol>
		</li>
		<li>Echocardiogram*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030</li>
		</ol>
		</li>
		<li>Angiogram
		<ol>
			<li>CT</li>
			<li>MRI</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	By Procedure Type

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type</li>
			<li>Market Attractiveness Index, By Procedure Type Segment</li>
		</ol>
		</li>
		<li>Transcatheter Aortic Valve Replacement (TAVR)*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030</li>
		</ol>
		</li>
		<li>Surgical Aortic Valve Replacement (SAVR)&nbsp;&nbsp;</li>
		<li>Transcatheter Mitral Valve Repair (TMVR)&nbsp;&nbsp;</li>
		<li>Left Atrial Appendage Closure (LAAC)</li>
		<li>Annuloplasty&nbsp;&nbsp;</li>
		<li>Valvuloplasty</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	By Application

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application Segment</li>
		</ol>
		</li>
		<li>Diagnosis*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030</li>
		</ol>
		</li>
		<li>Surgery</li>
	</ol>
	</li>
	<li>
	By End user

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Attractiveness Index, By End user Segment</li>
		</ol>
		</li>
		<li>Hospitals*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030</li>
		</ol>
		</li>
		<li>Specialty Clinics&nbsp;&nbsp;</li>
		<li>Cardiac Centers&nbsp;&nbsp;</li>
		<li>Diagnostic Centers&nbsp;&nbsp;</li>
		<li>Ambulatory Surgical Centers</li>
		<li>Others&nbsp;&nbsp;</li>
	</ol>
	</li>
	<li>
	By Region

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis, US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>U.K.</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Imaging Modality</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Procedure Type</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Competitive Landscape

	<ol>
		<li>Key Developments and Strategies</li>
		<li>Company Share Analysis</li>
		<li>Product Benchmarking</li>
		<li>List of Key Companies to Watch</li>
	</ol>
	</li>
	<li>
	Company Profiles

	<ol>
		<li>Boston Scientific Corporation*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Key Highlights</li>
			<li>Financial Overview</li>
		</ol>
		</li>
		<li>Circle Cardiovascular Imaging Inc.</li>
		<li>Absolute Medical Services, Inc.</li>
		<li>Pie Medical Imaging B.V.</li>
		<li>Siemens Healthineers GmbH</li>
		<li>Cardinal Health Inc.</li>
		<li>Koninklijke Philips NV</li>
		<li>GE HealthCare</li>
		<li>Neusoft Medical Systems</li>
		<li>Shimadzu Corporation&nbsp; &nbsp;&nbsp;(*LIST NOT EXHAUSTIVE)</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>Appendix</li>
		<li>About Us and Applications</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table1 Global Structural Heart Imaging Market Value, By Imaging Modality, 2022, 2026 &amp; 2030 ($ Million)

Table2 Global Structural Heart Imaging Market Value, By Procedure Type, 2022, 2026 &amp; 2030 ($ Million)

Table3 Global Structural Heart Imaging Market Value, By Application, 2022, 2026 &amp; 2030 ($ Million)

Table4 Global Structural Heart Imaging Market Value, By End user, 2022, 2026 &amp; 2030 ($ Million)

Table5 Global Structural Heart Imaging Market Value, By Region, 2022, 2026 &amp; 2030 ($ Million)

Table6 Global Structural Heart Imaging Market Value, By Imaging Modality, 2022, 2026 &amp; 2030 ($ Million)

Table7 Global Structural Heart Imaging Market Value, By Imaging Modality, 2022-2030 ($ Million)

Table8 Global Structural Heart Imaging Market Value, By Procedure Type, 2022, 2026 &amp; 2030 ($ Million)

Table9 Global Structural Heart Imaging Market Value, By Procedure Type, 2022-2030 ($ Million)

Table10 Global Structural Heart Imaging Market Value, By Application, 2022, 2026 &amp; 2030 ($ Million)

Table11 Global Structural Heart Imaging Market Value, By Application, 2022-2030 ($ Million)

Table12 Global Structural Heart Imaging Market Value, By End user, 2022, 2026 &amp; 2030 ($ Million)

Table13 Global Structural Heart Imaging Market Value, By End user, 2022-2030 ($ Million)

Table14 Global Structural Heart Imaging Market Value, By Region, 2022, 2026 &amp; 2030 ($ Million)

Table15 Global Structural Heart Imaging Market Value, By Region, 2022-2030 ($ Million)

Table16 North America Structural Heart Imaging Market Value, By Imaging Modality, 2022-2030 ($ Million)

Table17 North America Structural Heart Imaging Market Value, By Procedure Type, 2022-2030 ($ Million)

Table18 North America Structural Heart Imaging Market Value, By Application, 2022-2030 ($ Million)

Table19 North America Structural Heart Imaging Market Value, By End user, 2022-2030 ($ Million)

Table20 North America Structural Heart Imaging Market Value, By Country, 2022-2030 ($ Million)

Table21 South America Structural Heart Imaging Market Value, By Imaging Modality, 2022-2030 ($ Million)

Table22 South America Structural Heart Imaging Market Value, By Procedure Type, 2022-2030 ($ Million)

Table23 South America Structural Heart Imaging Market Value, By Application, 2022-2030 ($ Million)

Table24 South America Structural Heart Imaging Market Value, By End user, 2022-2030 ($ Million)

Table25 South America Structural Heart Imaging Market Value, By Country, 2022-2030 ($ Million)

Table26 Europe Structural Heart Imaging Market Value, By Imaging Modality, 2022-2030 ($ Million)

Table27 Europe Structural Heart Imaging Market Value, By Procedure Type, 2022-2030 ($ Million)

Table28 Europe Structural Heart Imaging Market Value, By Application, 2022-2030 ($ Million)

Table29 Europe Structural Heart Imaging Market Value, By End user, 2022-2030 ($ Million)

Table30 Europe Structural Heart Imaging Market Value, By Country, 2022-2030 ($ Million)

Table31 Asia-Pacific Structural Heart Imaging Market Value, By Imaging Modality, 2022-2030 ($ Million)

Table32 Asia-Pacific Structural Heart Imaging Market Value, By Procedure Type, 2022-2030 ($ Million)

Table33 Asia-Pacific Structural Heart Imaging Market Value, By Application, 2022-2030 ($ Million)

Table34 Asia-Pacific Structural Heart Imaging Market Value, By End user, 2022-2030 ($ Million)

Table35 Asia-Pacific Structural Heart Imaging Market Value, By Country, 2022-2030 ($ Million)

Table36 Middle East &amp; Africa Structural Heart Imaging Market Value, By Imaging Modality, 2022-2030 ($ Million)

Table37 Middle East &amp; Africa Structural Heart Imaging Market Value, By Procedure Type, 2022-2030 ($ Million)

Table38 Middle East &amp; Africa Structural Heart Imaging Market Value, By Application, 2022-2030 ($ Million)

Table39 Middle East &amp; Africa Structural Heart Imaging Market Value, By End user, 2022-2030 ($ Million)

Table40 Boston Scientific Corporation: Overview

Table41 Boston Scientific Corporation: Product Portfolio

Table42 Boston Scientific Corporation: Key Developments

Table43 Circle Cardiovascular Imaging Inc.: Overview

Table44 Circle Cardiovascular Imaging Inc.: Product Portfolio

Table45 Circle Cardiovascular Imaging Inc.: Key Developments

Table46 Absolute Medical Services, Inc.: Overview

Table47 Absolute Medical Services, Inc.: Product Portfolio

Table48 Absolute Medical Services, Inc.: Key Developments

Table49 Pie Medical Imaging B.V.: Overview

Table50 Pie Medical Imaging B.V.: Product Portfolio

Table51 Pie Medical Imaging B.V.: Key Developments

Table52 Siemens Healthineers GmbH: Overview

Table53 Siemens Healthineers GmbH: Product Portfolio

Table54 Siemens Healthineers GmbH: Key Developments

Table55 Cardinal Health Inc.: Overview

Table56 Cardinal Health Inc.: Product Portfolio

Table57 Cardinal Health Inc.: Key Developments

Table58 Koninklijke Philips NV: Overview

Table59 Koninklijke Philips NV: Product Portfolio

Table60 Koninklijke Philips NV: Key Developments

Table61 GE HealthCare: Overview

Table62 GE HealthCare: Product Portfolio

Table63 GE HealthCare: Key Developments

Table64 Neusoft Medical Systems: Overview

Table65 Neusoft Medical Systems: Product Portfolio

Table66 Neusoft Medical Systems: Key Developments

Table67 Shimadzu Corporation: Overview

Table68 Shimadzu Corporation: Product Portfolio

Table69 Shimadzu Corporation: Key Developments

List of Figures

Figure1 Global Structural Heart Imaging Market Share, By Imaging Modality, 2022 &amp; 2030 (%)

Figure2 Global Structural Heart Imaging Market Share, By Procedure Type, 2022 &amp; 2030 (%)

Figure3 Global Structural Heart Imaging Market Share, By Application, 2022 &amp; 2030 (%)

Figure4 Global Structural Heart Imaging Market Share, By End user, 2022 &amp; 2030 (%)

Figure5 Global Structural Heart Imaging Market Share, By Region, 2022 &amp; 2030 (%)

Figure6 Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure7 Global Structural Heart Imaging Market Y-o-Y Growth, By Imaging Modality, 2020-2028 (%)

Figure8 Echocardiogram: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure9 Angiogram: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure10 Global Structural Heart Imaging Market Y-o-Y Growth, By Procedure Type, 2020-2028 (%)

Figure11 Transcatheter Aortic Valve Replacement (TAVR)&nbsp;&nbsp;: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure12 Surgical Aortic Valve Replacement (SAVR)&nbsp;&nbsp;: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure13 Transcatheter Mitral Valve Repair (TMVR)&nbsp;&nbsp;: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure14 Left Atrial Appendage Closure (LAAC): Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure15 Annuloplasty&nbsp;&nbsp;: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure16 Valvuloplasty: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure17 Others: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure18 Global Structural Heart Imaging Market Y-o-Y Growth, By Application, 2020-2028 (%)

Figure19 Diagnosis: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure20 Surgery: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure21 Global Structural Heart Imaging Market Y-o-Y Growth, By End user, 2020-2028 (%)

Figure22 Hospitals: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure23 Specialty Clinics: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure24 Cardiac Centers: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure25 Diagnostic Centers: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure26 Ambulatory Surgical Centers: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure27 Others: Global Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure28 Global Structural Heart Imaging Market Y-o-Y Growth, By Region, 2022-2030&nbsp;(%)

Figure29 North America Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure30 North America Structural Heart Imaging Market Share, By Imaging Modality, 2022 &amp; 2030 (%)

Figure31 North America Structural Heart Imaging Market Share, By Procedure Type, 2022 &amp; 2030 (%)

Figure32 North America Structural Heart Imaging Market Share, By Application, 2022 &amp; 2030 (%)

Figure33 North America Structural Heart Imaging Market Share, By End user, 2022 &amp; 2030 (%)

Figure34 North America Structural Heart Imaging Market Share, By Country, 2022 &amp; 2030 (%)

Figure35 South America Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure36 South America Structural Heart Imaging Market Share, By Imaging Modality, 2022 &amp; 2030 (%)

Figure37 South America Structural Heart Imaging Market Share, By Procedure Type, 2022 &amp; 2030 (%)

Figure38 South America Structural Heart Imaging Market Share, By Application, 2022 &amp; 2030 (%)

Figure39 South America Structural Heart Imaging Market Share, By End user, 2022 &amp; 2030 (%)

Figure40 South America Structural Heart Imaging Market Share, By Country, 2022 &amp; 2030 (%)

Figure41 Europe Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure42 Europe Structural Heart Imaging Market Share, By Imaging Modality, 2022 &amp; 2030 (%)

Figure43 Europe Structural Heart Imaging Market Share, By Procedure Type, 2022 &amp; 2030 (%)

Figure44 Europe Structural Heart Imaging Market Share, By Application, 2022 &amp; 2030 (%)

Figure45 Europe Structural Heart Imaging Market Share, By End user, 2022 &amp; 2030 (%)

Figure46 Europe Structural Heart Imaging Market Share, By Country, 2022 &amp; 2030 (%)

Figure47 Asia-Pacific Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure48 Asia-Pacific Structural Heart Imaging Market Share, By Imaging Modality, 2022 &amp; 2030 (%)

Figure49 Asia-Pacific Structural Heart Imaging Market Share, By Procedure Type, 2022 &amp; 2030 (%)

Figure50 Asia-Pacific Structural Heart Imaging Market Share, By Application, 2022 &amp; 2030 (%)

Figure51 Asia-Pacific Structural Heart Imaging Market Share, By End user, 2022 &amp; 2030 (%)

Figure52 Asia-Pacific Structural Heart Imaging Market Share, By Country, 2022 &amp; 2030 (%)

Figure53 Middle East &amp; Africa Structural Heart Imaging Market Value, 2022-2030 ($ Million)

Figure54 Middle East &amp; Africa Structural Heart Imaging Market Share, By Imaging Modality, 2022 &amp; 2030 (%)

Figure55 Middle East &amp; Africa Structural Heart Imaging Market Share, By Procedure Type, 2022 &amp; 2030 (%)

Figure56 Middle East &amp; Africa Structural Heart Imaging Market Share, By Application, 2022 &amp; 2030 (%)

Figure57 Middle East &amp; Africa Structural Heart Imaging Market Share, By End user, 2022 &amp; 2030 (%)

Figure58 Boston Scientific Corporation: Financials

Figure59 Circle Cardiovascular Imaging Inc.: Financials

Figure60 Absolute Medical Services, Inc.: Financials

Figure61 Pie Medical Imaging B.V.: Financials

Figure62 Siemens Healthineers GmbH: Financials

Figure63 Cardinal Health Inc.: Financials

Figure64 Koninklijke Philips NV: Financials

Figure65 GE HealthCare: Financials

Figure66 Neusoft Medical Systems: Financials

Figure67 Shimadzu Corporation: Financials

Structural Heart Imaging Market Size, Share, Industry, Forecast and outlook (2023-2030)

Vascular Imaging Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 06

Starting from

Nuclear Imaging Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 13

Starting from

Veterinary Imaging Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 May 17

Starting from

Breast Imaging Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 June 24

Starting from

Dental Imaging Equipment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 May 22

Starting from

Medical Imaging Equipment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 April 29

Starting from